Tempus AI (NASDAQ:TEM) CEO Ryan Fukushima Sells 700 Shares

Tempus AI, Inc. (NASDAQ:TEM) CEO Ryan Fukushima sold 700 shares of Tempus AI stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $70.00, for a total value of $49,000.00. Following the sale, the chief executive officer owned 15,874 shares of the company’s stock, valued at approximately $1,111,180. This trade represents a 4.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ryan Fukushima also recently made the following trade(s):

• On Friday, August 21st, Ryan Fukushima sold 14,286 shares of Tempus AI stock. The stock was sold at an average price of $70.00, for a total transaction of $1,000,020.00.
• On Tuesday, August 18th, Ryan Fukushima sold 41,095 shares of Tempus AI stock. The stock was sold at an average price of $49.61, for a total transaction of $2,038,722.95.
• On Friday, August 7th, Ryan Fukushima sold 20,000 shares of Tempus AI stock. The shares were sold at an average price of $50.04, for a total transaction of $1,000,800.00.
• On Monday, August 3rd, Ryan Fukushima sold 23,818 shares of Tempus AI stock. The shares were sold at an average price of $46.19, for a total transaction of $1,100,153.42.
• On Wednesday, July 8th, Ryan Fukushima sold 33,284 shares of Tempus AI stock. The shares were sold at an average price of $57.39, for a total transaction of $1,910,168.76.
• On Monday, July 6th, Ryan Fukushima sold 10,000 shares of Tempus AI stock. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00.

Tempus AI Stock Performance

Shares of NASDAQ:TEM opened at $77.84 on Friday. The firm’s 50 day simple moving average is $57.19 and its 200-day simple moving average is $52.90. The company has a debt-to-equity ratio of 3.06, a quick ratio of 3.16 and a current ratio of 3.30. Tempus AI, Inc. has a one year low of $40.77 and a one year high of $104.32. The firm has a market cap of $14.04 billion, a PE ratio of -54.06 and a beta of 3.72.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.10. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%.The firm had revenue of $382.49 million during the quarter, compared to analyst estimates of $379.69 million. During the same quarter in the previous year, the business earned ($0.22) earnings per share. Tempus AI’s quarterly revenue was up 21.6% on a year-over-year basis. As a group, equities analysts predict that Tempus AI, Inc. will post -1.38 EPS for the current year.

Tempus AI News Roundup

Here are the key news stories impacting Tempus AI this week:

• Positive Sentiment: CEO commentary outlining Tempus AI’s growth strategy and projected Medicare revenue has strengthened confidence that reimbursement expansion could provide a significant new revenue stream. Tempus AI Stock Roars Back 92% From July Low After CEO Lays Out Growth Plan
• Positive Sentiment: Morgan Stanley’s updated outlook reportedly incorporated additional reimbursement-driven revenue potential, helping fuel a sharp weekly advance in TEM shares and reinforcing the bullish growth narrative. Tempus AI Is Ripping 30% Higher This Week After Morgan Stanley Boosts Revenue Outlook
• Positive Sentiment: Trading momentum remains strong: shares have rebounded roughly 92% to 95% from the July low, with market capitalization moving above $14 billion. Above-average volume and elevated call-option activity indicate substantial speculative interest. Tempus AI Stock Is Soaring
• Neutral Sentiment: Analysts and market commentators are assessing whether the recent surge can continue. The rally has improved sentiment, but the sharp move also raises the risk of profit-taking and increased volatility. Strength Seen in Tempus
• Negative Sentiment: Zacks cautioned that recent earnings-estimate revision trends may not support another near-term advance, while brokerages maintain an average “Hold” rating. Tempus also remains unprofitable, making the stock particularly sensitive to valuation concerns and changes in growth expectations. Tempus AI Receives Average Hold Rating

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on TEM shares. Raymond James Financial set a $80.00 price target on Tempus AI in a research report on Wednesday, September 2nd. Guggenheim lifted their price objective on Tempus AI from $60.00 to $65.00 and gave the company a “buy” rating in a report on Thursday, July 16th. Piper Sandler raised shares of Tempus AI from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $56.00 to $76.00 in a research note on Tuesday, September 1st. HC Wainwright increased their target price on shares of Tempus AI from $56.00 to $66.00 and gave the stock a “buy” rating in a report on Friday, September 11th. Finally, Wall Street Zen raised shares of Tempus AI from a “sell” rating to a “hold” rating in a research report on Saturday, July 25th. Eleven research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Tempus AI has an average rating of “Hold” and a consensus target price of $69.33.

Institutional Investors Weigh In On Tempus AI

A number of hedge funds and other institutional investors have recently bought and sold shares of TEM. Amova Asset Management Americas Inc. boosted its stake in Tempus AI by 1.2% in the fourth quarter. Amova Asset Management Americas Inc. now owns 3,504,823 shares of the company’s stock valued at $206,960,000 after acquiring an additional 41,728 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its position in shares of Tempus AI by 23.4% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,326,313 shares of the company’s stock worth $195,636,000 after purchasing an additional 821,490 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Tempus AI by 8.2% during the 4th quarter. Geode Capital Management LLC now owns 1,870,510 shares of the company’s stock valued at $110,478,000 after purchasing an additional 141,680 shares during the last quarter. Franklin Resources Inc. lifted its holdings in shares of Tempus AI by 27.9% during the 4th quarter. Franklin Resources Inc. now owns 1,861,782 shares of the company’s stock valued at $109,938,000 after purchasing an additional 405,662 shares during the last quarter. Finally, Lingotto Investment Management LLP boosted its position in shares of Tempus AI by 45.9% in the 4th quarter. Lingotto Investment Management LLP now owns 1,143,526 shares of the company’s stock worth $67,525,000 after purchasing an additional 359,667 shares in the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI, Inc is a healthcare technology company focused on applying artificial intelligence and data analytics to precision medicine. The company combines molecular testing, clinical data and machine learning to help physicians make more informed treatment decisions and support the development of new therapies.

Tempus provides genomic and diagnostic testing services, including testing intended to identify clinically relevant mutations and other biomarkers. Its technology platform also organizes and analyzes clinical and molecular data, while its AI-enabled tools are designed to assist healthcare professionals with patient care, research and workflow management.

The company serves healthcare providers, patients, pharmaceutical companies and biotechnology researchers, primarily in the United States.